Structures by: Hughes D. S.
Total: 26
Triamterene, succinic acid and DMSO
C12H12N71,C4H5O41,C2H6OS
IUCrJ (2018) 5, 3
a=13.5226(7)Å b=14.9966(7)Å c=10.6958(5)Å
α=90° β=104.179(2)° γ=90°
Triamterene, acetic acid and DMSO
C12H12N71,C2H6OS,C2H3O21
IUCrJ (2018) 5, 3
a=10.8022(2)Å b=13.9084(2)Å c=14.6076(3)Å
α=115.2840(10)° β=109.088(2)° γ=90.5250(10)°
Triamterene, adipic acid and DMSO
2(C12H12N7),C6H8O4,2(C2H6OS)
IUCrJ (2018) 5, 3
a=11.0286(3)Å b=13.7429(4)Å c=14.9742(5)Å
α=115.247(2)° β=109.951(4)° γ=90.122(2)°
Triamterene, azelaic acid and DMSO
2(C12H12N71),C9H14O42,2(C2H6OS)
IUCrJ (2018) 5, 3
a=15.0338(3)Å b=11.5004(2)Å c=24.3960(6)Å
α=90° β=104.5390(10)° γ=90°
Triamterene, pimelic acid and DMSO
2(C12H12N71),C7H10O42,2(C2H6OS)
IUCrJ (2018) 5, 3
a=14.0750(5)Å b=14.8889(6)Å c=19.635(2)Å
α=86.408(2)° β=88.142(3)° γ=71.702(2)°
Triamterene, nicotinic acid and DMSO
C12H12N71,C12H11N7,C6H4NO21,2(C2H6OS)
IUCrJ (2018) 5, 3
a=14.8461(2)Å b=12.3081(3)Å c=21.2850(5)Å
α=90° β=105.1760(10)° γ=90°
Triamterene and Ibuprofen salt, DMSO solvate
C12H12N71,C12H11N7,C13H17O21,C2H6OS
IUCrJ (2018) 5, 3
a=11.2398(3)Å b=13.2439(3)Å c=15.4624(4)Å
α=113.595(2)° β=103.527(3)° γ=91.977(2)°
Triamterene
C12H11N7
Chemistry Central Journal (2017) 63, 11
a=7.4432(15)Å b=9.993(2)Å c=16.648(3)Å
α=77.55(2)° β=87.54(3)° γ=87.09(3)°
TriboIV
C28H22N2O2
Chemistry Central journal (2014) 8, 1 70
a=8.610(4)Å b=12.780(5)Å c=20.458(8)Å
α=90.00° β=101.72(3)° γ=90.00°
TriboII
C25H18N2O2
Chemistry Central journal (2014) 8, 1 70
a=14.38400(10)Å b=8.2140(5)Å c=17.3650(9)Å
α=90.00° β=105.530(3)° γ=90.00°
TriboIIIa
C27H20N2O2
Chemistry Central journal (2014) 8, 1 70
a=10.07(3)Å b=23.91(5)Å c=9.50(5)Å
α=90.00° β=110.38(18)° γ=90.00°
TriboIIIb
C27H20N2O2
Chemistry Central journal (2014) 8, 1 70
a=20.349(2)Å b=10.095(2)Å c=21.338(2)Å
α=90.00° β=99.060(18)° γ=90.00°
TriboI
C23H16N2O2
Chemistry Central journal (2014) 8, 1 70
a=10.3520(4)Å b=7.21200(10)Å c=13.3200(9)Å
α=90.00° β=110.332(2)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
Crystal Structure Report Archive (2004) 398
a=8.193(2)Å b=8.538(2)Å c=15.437(3)Å
α=90.00° β=94.01(3)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
Crystal Structure Report Archive (2004) 399
a=10.7740(10)Å b=8.4670(10)Å c=11.3670(10)Å
α=90.00° β=91.650(10)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
Crystal Structure Report Archive (2004) 401
a=10.534(2)Å b=12.936(3)Å c=17.191(3)Å
α=90.00° β=107.77(3)° γ=90.00°
C19H20O3S
C19H20O3S
Chemical Communications (2000) 17 1567
a=10.773(2)Å b=7.861(2)Å c=19.492(4)Å
α=90.00° β=92.42(3)° γ=90.00°
C22H20N2O3
C22H20N2O3
Chemical Communications (2000) 15 1397
a=9.372(8)Å b=11.198(7)Å c=17.679(7)Å
α=90.00° β=101.07(4)° γ=90.00°
Sulfathiazole-N-Formyl piperidine co-crystal
C15H20N4O3S2
Chemical Communications (2001) 7 603
a=10.539(2)Å b=12.189(2)Å c=13.981(3)Å
α=95.29(3)° β=107.38(3)° γ=90.63(3)°
Sulfathiazole - Acetonitrile Clathrate
C11H12N4O2S2
Chemical Communications (2001) 7 603
a=10.741(2)Å b=7.592(2)Å c=16.748(3)Å
α=90.00° β=103.99(3)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2008) 10, 10 1328
a=10.399(2)Å b=15.132(3)Å c=14.280(3)Å
α=90° β=91.21(3)° γ=90°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2008) 10, 10 1328
a=8.193(2)Å b=8.538(2)Å c=15.437(3)Å
α=90.00° β=94.01(3)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2008) 10, 10 1328
a=10.7740(10)Å b=8.4670(10)Å c=11.3670(10)Å
α=90.00° β=91.650(10)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2008) 10, 10 1328
a=10.534(2)Å b=12.936(3)Å c=17.191(3)Å
α=90.00° β=107.77(3)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2008) 10, 10 1328
a=17.448(3)Å b=8.498(2)Å c=15.511(3)Å
α=90.00° β=112.81(3)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
Acta Crystallographica Section C (1999) 55, 11 1831-1833
a=10.399(2)Å b=15.132(3)Å c=14.280(3)Å
α=90° β=91.21(3)° γ=90°